Indeed, inflammation is a prominent feature of mild cognitive impairment and AD [149, 150]; elevated pro-inflammatory cytokines and chemokines have frequently been observed in the cerebrospinal fluid from patients with cognitive impairment or AD and are associated with amyloid and tau pathology [151, 152]. Here, MAPT is linked to Alzheimer disease.